Hantz Financial Services, Inc. Inovio Pharmaceuticals, Inc. Transaction History

Hantz Financial Services, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Aug 06, 2024	SELL	$1.41 - $2.5 $35 - $62	-25 Reduced 18.94%	107 $0
Q3 2022 Aug 06, 2024	BUY	$1.66 - $2.79 $41 - $69	25 Added 23.36%	132 $0
Q1 2022 Aug 06, 2024	BUY	$2.97 - $5.2 $59 - $104	20 Added 22.99%	107 $0
Q3 2021 Aug 06, 2024	SELL	$7.16 - $9.69 $27,924 - $37,791	-3,900 Reduced 97.82%	87 $1,000
Q2 2021 Aug 06, 2024	BUY	$6.23 - $10.03 $24,839 - $39,989	3,987 New	3,987 $37,000
Q3 2020 Aug 06, 2024	BUY	$9.57 - $27.05 $30,690 - $86,749	3,207 New	3,207 $37,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $566M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Hantz Financial Services, Inc., based on Form 13F filings with the SEC.

Stay updated on Hantz Financial Services, Inc. with notifications on news.